These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1932245)

  • 1. [Validity of preclinical research in the development of new antibiotics. Pharmacokinetic aspects].
    Calvo B; Pedraz JL; Gascón AR; Domínguez-Gil A
    Enferm Infecc Microbiol Clin; 1991; 9(6):361-9. PubMed ID: 1932245
    [No Abstract]   [Full Text] [Related]  

  • 2. [Animal model and drug activity (proceedings)].
    Rico AG
    Ann Biol Clin (Paris); 1978; 36(3):214-7. PubMed ID: 101102
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of antineoplastic agents and experimental animals].
    Hoshi A
    Jikken Dobutsu; 1978 Jan; 27(1):63-9. PubMed ID: 415888
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of the dipeptidyl peptidase 4 inhibitor saxagliptin in rats, dogs, and monkeys and clinical projections.
    Fura A; Khanna A; Vyas V; Koplowitz B; Chang SY; Caporuscio C; Boulton DW; Christopher LJ; Chadwick KD; Hamann LG; Humphreys WG; Kirby M
    Drug Metab Dispos; 2009 Jun; 37(6):1164-71. PubMed ID: 19251818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical pharmacology of 2-methoxyantimycin A compounds as novel antitumor agents.
    Wang H; Li M; Rhie JK; Hockenbery DM; Covey JM; Zhang R; Hill DL
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):291-8. PubMed ID: 15883820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of different doses of cisplatin on the pharmacokinetic parameters of cefepime in mice.
    Máthé A; Komka K; Forczig M; Szabó D; Anderlik P; Rozgonyi F
    Lab Anim; 2006 Jul; 40(3):296-300. PubMed ID: 16803647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical pharmacokinetics and in vitro activity of ON 01910.Na, a novel anti-cancer agent.
    Chun AW; Cosenza SC; Taft DR; Maniar M
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):177-86. PubMed ID: 19466411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of interspecies scaling to the bispyridinium oxime HI-6.
    Baggot JD
    Am J Vet Res; 1994 May; 55(5):689-91. PubMed ID: 8067618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of the preclinical toxicological study of antibacterial agents].
    Gus'kova TA
    Farmakol Toksikol; 1985; 48(3):119-22. PubMed ID: 3896843
    [No Abstract]   [Full Text] [Related]  

  • 10. Preclinical toxicology of anticancer agents.
    Schein PS
    Cancer Res; 1977 Jun; 37(6):1934-7. PubMed ID: 404039
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics and dose proportionality of oral moxidectin in beagle dogs.
    Vanapalli SR; Hung YP; Fleckenstein L; Dzimianski MT; McCall JW
    Biopharm Drug Dispos; 2002 Oct; 23(7):263-72. PubMed ID: 12355577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of radioactively labeled glisoxepide in the animal].
    Kolb KH; Schulze PE; Speck U; Acksteiner B
    Arzneimittelforschung; 1974 Mar; 24(0):397-403. PubMed ID: 4211553
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of pharmacodynamic research in the assessment and development of new antibacterial drugs.
    Lister PD
    Biochem Pharmacol; 2006 Mar; 71(7):1057-65. PubMed ID: 16316633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interspecies pharmacokinetic scaling of DA-8159, a new erectogenic, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
    Shim HJ; Kim YC; Lee JH; Kwon JW; Kim WB; Kim YG; Kim SH; Lee MG
    Biopharm Drug Dispos; 2005 Oct; 26(7):269-77. PubMed ID: 15991256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of recombinant human factor IX: pharmacokinetic studies in the rat and the dog.
    Keith JC; Ferranti TJ; Misra B; Frederick T; Rup B; McCarthy K; Faulkner R; Bush L; Schaub RG
    Thromb Haemost; 1995 Jan; 73(1):101-5. PubMed ID: 7740479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of thiamphenicol in dogs.
    Castells G; Intorre L; Franquelo C; Cristòfol C; Pérez B; Martí G; Arboix M
    Am J Vet Res; 1998 Nov; 59(11):1473-5. PubMed ID: 9829409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new Russian immunomodulating and anti-inflammatory preparation].
    Abidov MT; Kaliuzhin OV; Grishina TI
    Voen Med Zh; 1999 Jan; 320(1):41-5. PubMed ID: 10200624
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacokinetics as the foundation of drug therapy].
    Hitzenberger G
    Wien Med Wochenschr; 1973 Nov; 123(45):653-7. PubMed ID: 4750618
    [No Abstract]   [Full Text] [Related]  

  • 19. [Problem of species specificity in the study of drug metabolism].
    Shindo H
    Jikken Dobutsu; 1978 Jan; 27(1):51-61. PubMed ID: 305360
    [No Abstract]   [Full Text] [Related]  

  • 20. Preclinical pharmacokinetics of a novel HIV-1 attachment inhibitor BMS-378806 and prediction of its human pharmacokinetics.
    Yang Z; Zadjura L; D'Arienzo C; Marino A; Santone K; Klunk L; Greene D; Lin PF; Colonno R; Wang T; Meanwell N; Hansel S
    Biopharm Drug Dispos; 2005 Dec; 26(9):387-402. PubMed ID: 16142720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.